Seftel: Prospective cohort of fluvoxamine for early treatment of COVID-19

Seftel, 125 patient fluvoxamine early treatment study: 84% lower combined mortality/ICU admission [p=0.15], 94% lower hospitalization [p=0.003], and 99% improved recovery [p<0.0001] https://c19p.org/seftel

copied to clipboard

Prospective cohort of fluvoxamine for early treatment of COVID-19

Seftel et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofab050

1 Feb 2021 Source PDF Share Tweet

Prospective quasi-randomized (patient choice) study with 125 outpatients, 77 treated with fluvoxamine, showing lower death/ICU admission (0 of 77 vs. 2 of 48), lower hospitalization (0 of 77 vs. 6 of 48), and faster recovery with treatment. Note that 12 treatment patients were added but are not reflected in the table in the paper (because the numbers had been previously published and the IRB did not allow updating the table).

Important missing comments or errors? Let us know.

risk of death/ICU, 83.9% lower, RR 0.16, p = 0.15, treatment 0 of 77 (0.0%), control 2 of 48 (4.2%), NNT 24, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).

risk of hospitalization, 94.0% lower, RR 0.06, p = 0.003, treatment 0 of 77 (0.0%), control 6 of 48 (12.5%), NNT 8.0, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).

risk of no recovery, 98.7% lower, RR 0.01, p < 0.001, treatment 0 of 77 (0.0%), control 29 of 48 (60.4%), NNT 1.7, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Seftel et al., 1 Feb 2021, prospective quasi-randomized (patient choice), USA, peer-reviewed, 2 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Fluvoxamine All

Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit